Next article Search Articles Instructions for authors  Access Statistics | Citation Manager  
CASE REPORT  

 Article Access Statistics
    Viewed2619    
    Printed99    
    Emailed1    
    PDF Downloaded216    
    Comments [Add]    

Recommend this journal

Use of nitric oxide in thoracic surgery for a high risk cardiac patient


1 Department of Cardiothoracic and Transplant Anaesthesia, Freeman Hospital, Newcastle Upon Tyne, United Kingdom
2 Department of Cardiothoracic Surgery, Freeman Hospital, Newcastle Upon Tyne, United Kingdom

Correspondence Address:
Vishal Garg
Department of Cardiothoracic Anaesthesia, Freeman Hospital, Newcastle Upon Tyne, NE7 7DN
United Kingdom
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-9784.129882

Rights and Permissions

Year : 2014  |  Volume : 17  |  Issue : 2  |  Page : 167-169

 

SEARCH
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles

  Article in PDF (245 KB)
Email article
Print Article
Add to My List
Nitric oxide (NO) is a selective pulmonary vasodilator especially in the presence of pulmonary artery hypertension. With right ventricle (RV) dysfunction, inhaled NO may increase RV ejection fraction and cardiac output. The main advantage of NO over intravenous therapy is its inability to decrease systemic pressure thereby maintaining the coronary perfusion pressure and the myocardial perfusion. In this case report, we discuss the use of NO in a routine thoracic surgery patient suffering with severe left ventricular dysfunction and a potential candidate for a very high cardiac risk.






[FULL TEXT] [PDF]*
 

 

 

 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 
 
 Reader Comments
 Email Alert *
  *
 * Requires registration (Free)
 
 CASE REPORT
 




1 Department of Cardiothoracic and Transplant Anaesthesia, Freeman Hospital, Newcastle Upon Tyne, United Kingdom
2 Department of Cardiothoracic Surgery, Freeman Hospital, Newcastle Upon Tyne, United Kingdom

Correspondence Address:
Vishal Garg
Department of Cardiothoracic Anaesthesia, Freeman Hospital, Newcastle Upon Tyne, NE7 7DN
United Kingdom
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0971-9784.129882

Rights and Permissions

Nitric oxide (NO) is a selective pulmonary vasodilator especially in the presence of pulmonary artery hypertension. With right ventricle (RV) dysfunction, inhaled NO may increase RV ejection fraction and cardiac output. The main advantage of NO over intravenous therapy is its inability to decrease systemic pressure thereby maintaining the coronary perfusion pressure and the myocardial perfusion. In this case report, we discuss the use of NO in a routine thoracic surgery patient suffering with severe left ventricular dysfunction and a potential candidate for a very high cardiac risk.






[FULL TEXT] [PDF]*


        
Print this article     Email this article